Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.9 which represents no change from the prior close of of $1.9. The stock opened at $1.9 and touched a low of $1.87 during ...

BTIG analyst Julian Harrison initiated coverage with a Buy rating on VYNE Therapeutics (VYNE – Research Report) on December 30 and set a price target of $8.00. The company’s shares closed yesterday at ...

FTAI Aviation Ltd (FTAI) stock saw a modest uptick, ending the day at $144.44 which represents a slight increase of $0.40 or 0.28% from the prior close of $144.04. The stock opened at $145 and touched ...

BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...

MicroStrategy Inc. (NASDAQ:MSTR) experienced a notable 5.87% increase in its stock during pre-market trading on Thursday.

BTIG raised the firm’s price target on Verastem (VSTM) to $20 from $13 and keeps a Buy rating on the shares after the company announced the FDA ...

BTIG said it would be cautious on Apple's (NASDAQ:AAPL) stock heading into January 2025. Analyst Jonathan Krinsky said the ...

A deal announced last month by struggling travel site Tripadvisor to simplify its ownership structure could help the company ...

Equities research analysts at BTIG Research assumed coverage on shares of SunCar Technology Group (NASDAQ:SDA – Get Free ...

According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...